got pregnant while taking tirzepatide and Pregnancy tirzepatide pregnancy use guidelines I

Some patients experience meaningful weight loss at lower doses (0.51.0 mg), while others require higher therapeutic doses (2.02.4 mg) to achieve their goals

The milligram figure is route-specific, not a stronger dose than the injection

If weight loss slows down or energy stays low, this guide explains why patients stop losing weight by looking at metabolic and nutritional reasons

Ann Neurol 1988;24:301

GLP-1 receptor agonists and gastrointestinal effects: Medications such as semaglutide commonly cause nausea, vomiting, and abdominal discomfort (per the Wegovy SmPC), which may be difficult to distinguish from, or may worsen, existing endometriosis-related gastrointestinal symptoms such as bloating and bowel pain